A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

NCT03311932 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Adrenal Insufficiency

Interventions

DRUG: Infacort®
DRUG: Cortef®

Sponsor

Neurocrine UK Limited

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]